Understanding GLP-1 Analogues for Diabetes Management in the USAThe landscape of Type 2 Diabetes (T2D) management in the United States has actually undergone a seismic shift over the last years. Among the most substantial improvements in this field is the advancement and widespread adoption of Glucagon-Like Peptide-1 (GLP-1) receptor agonists,
